Exane Derivatives’s ScottsMiracle-Gro SMG Stock Holding History

Exane Derivatives’s Portfolio SMG Stock Details SMG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$426K	Sell	5,400 -1,376	-20%	-$136K	0.25%	102
2022 Q1	$833K	Sell	6,776 -23	-0.3%	-$3.22K	0.23%	115
2021 Q4	$1.09M	Buy	+6,799	New	+$1.05M	0.26%	79
2021 Q2	–	Sell	-204	Closed	-$50K	–	1079
2021 Q1	$50K	Buy	+204	New	+$46.2K	0.01%	516

Other funds holding SMG

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Exane Derivatives's SMG Position: Q2 2022 in Review

Exane Derivatives reduced its ScottsMiracle-Gro (SMG) stake by 20% in Q2 2022, selling an estimated $136K and leaving 5,400 shares worth $426K. The position accounts for 0.25% of the portfolio, ranked #102.

Exane Derivatives first reported a position in SMG in Q1 2021 and has held it in 4 quarters since. The position peaked at $1.09M in Q4 2021. 461 funds tracked by Wall St. Rank hold SMG as of Q2 2022.

Exane Derivatives held 5,400 shares of ScottsMiracle-Gro worth $426K as of Q2 2022.
Exane Derivatives sold 1,376 ScottsMiracle-Gro shares in Q2 2022, an estimated $136K.
ScottsMiracle-Gro made up 0.25% of Exane Derivatives's portfolio in Q2 2022, its #102 holding.
Exane Derivatives first reported a position in ScottsMiracle-Gro in Q1 2021 and has held it in 4 quarters since.
Exane Derivatives's ScottsMiracle-Gro position peaked at $1.09M in Q4 2021.
461 funds tracked by Wall St. Rank held ScottsMiracle-Gro as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.